Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer By Ogkologos - November 4, 2024 1955 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG S1011 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Scanxiety September 15, 2021 Medical Assistant Diagnosed with Breast Cancer While Volunteering as Patient for... May 7, 2021 Patients with Advanced Hodgkin’s Lymphoma Treated with Brentuximab Vedotin Plus AVD... July 19, 2022 Program Helps Medically Underserved, Minority Cancer Survivors Be More Active July 3, 2024 Load more HOT NEWS FDA Approves Fam-Trastuzumab Deruxtecan-nxki for HER2-positive Gastric Adenocarcinomas Searching for novel connections in cancer metabolism GreaterGood Has Donated More Than 2 Million Masks to Frontline Workers... Survivors of Childhood Cancer are at Excess Risk of Late Mortality...
